| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 218.0 | 209.3 | 190.4 |
| Other income | 17.8 | 17.4 | 18.7 |
| Total income | 235.8 | 226.7 | 209.0 |
| Profit before exceptional items & tax | 26.0 | 21.7 | 27.6 |
| Exceptional items | 3.5 | -7.6 | -5.9 |
| Profit before tax | 29.5 | 14.1 | 21.8 |
| Net profit | 21.8 | 10.5 | 16.1 |
| Operating margin | 12.5% | 6.2% | 10.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +35.40% |
|---|---|
| Net profit, quarter on quarter | +107.60% |
| Revenue, year on year | +14.50% |
NSE results filing, NSE: TTKHLTCARE. Figures extracted from the filing.
TTK Healthcare Ltd: key numbers
- Share price
- ₹1,031.10
- Market cap
- ₹1,457 Cr
- Revenue (annual)
- ₹857.3 Cr
- Net profit (annual)
- ₹65.68 Cr
- P/E (TTM)
- 19.7×Sector 23.2×
- Promoter holding
- 74.56%+0.00% QoQ
- FII holding
- 1.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TTK Healthcare Ltd
All →TTK Healthcare Merger & Restructuring Worth ₹256 Cr
TTK Healthcare completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises. The company received Rs. 256 crore in cash consideration.
- Value
- ₹256.0 Cr
TTK Healthcare Other Announcement
TTK Healthcare Limited has appointed M/s. R V K & Co., Chartered Accountants, as the Company's Tax Auditor. The appointment is for a three-year term covering FY 2025-26 to 2027-28.
- Execution
- 3 years
TTK Healthcare Q1 FY27 Results: Net Profit ₹21.3 Cr, Up 63.8% YoY
TTK Healthcare Ltd reported revenue from operations of ₹257.6 Cr (+13.8% YoY) and net profit of ₹21.3 Cr (+63.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹21.3 Cr · +63.8% YoY